$3.18
Neuraxis is a biotechnology business based in the US. Neuraxis shares (NRXS) are listed on the NYSE MKT and all prices are listed in US Dollars. Neuraxis employs 19 staff and has a trailing 12-month revenue of around $2.3 million.
Our top picks for where to buy Neuraxis stock
How to buy Neuraxis stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NRXS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Neuraxis stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Neuraxis stock price (NYSE MKT: NRXS)
Use our graph to track the performance of NRXS stocks over time.Neuraxis shares at a glance
Latest market close | $3.12 |
---|---|
52-week range | $1.80 - $6.93 |
50-day moving average | $3.05 |
200-day moving average | $3.00 |
Wall St. target price | $7.50 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.21 |
Is it a good time to buy Neuraxis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neuraxis price performance over time
Historical closes compared with the close of $3.12 from 2024-07-23
1 week (2024-07-17) | 7.77% |
---|---|
1 month (2024-06-24) | 21.88% |
3 months (2024-04-24) | 4.00% |
6 months (2024-01-24) | 33.91% |
1 year (2023-07-20) | N/A |
---|---|
2 years (2022-07-20) | N/A |
3 years (2021-07-20) | N/A |
5 years (2019-07-20) | N/A |
Neuraxis financials
Revenue TTM | $2.3 million |
---|---|
Gross profit TTM | $0 |
Return on assets TTM | -376.39% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | $-0.48 |
Market Capitalization | $16.4 million |
TTM: trailing 12 months
Neuraxis share dividends
We're not expecting Neuraxis to pay a dividend over the next 12 months.
Neuraxis overview
NeurAxis, Inc. , a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022.
Frequently asked questions
nullWhat percentage of Neuraxis is owned by insiders or institutions?
Currently 49.328% of Neuraxis shares are held by insiders and 1.199% by institutions. How many people work for Neuraxis?
Latest data suggests 19 work at Neuraxis. When does the fiscal year end for Neuraxis?
Neuraxis's fiscal year ends in December. Where is Neuraxis based?
Neuraxis's address is: 11550 North Meridian Street, Carmel, IN, United States, 46032
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
How to buy Pershing Square USA stock when it goes public
Everything we know about the Pershing Square USA IPO, plus information on how to buy in.
-
Compare top business loan marketplaces
Too busy to look for lenders on your own? Consider a business loan marketplace to apply once and get connected with multiple offers.
-
5 Smart Places to Invest After Maximizing a 401(k)
If you’ve maxed out your IRA, here are other 5 potential options to grow your retirement savings.
-
Alternatives to PayPal
Some of the closest PayPal alternatives include Cash App, Chime, Zelle, Revolut, Meta Pay and Apple Pay. Compare these apps here.
-
Fifth Third Bank promotions and bonus offers of July 2024
Fifth Third Bank currently offers a $250 checking account bonus when you open a new account and set up qualifying direct deposits.
-
Current vs. Chime: Which fintech is right for you?
Current wins for its high-APY savings pods and positive customer reviews, but Chime is still a good pick for credit-building.
-
Credit9 Personal Loans Review: Avoid Bad Partner Offers
Credit9 offers debt consolidation loans, but beware of misleading promotions from its partner company.
-
Guaranteed approval credit cards for bad credit
Guaranteed approval credit cards don’t exist, but there are good options with a nearly instant approval process for bad credit.
-
What is invoice financing? How this fast yet pricey funding works
Invoice financing can help your business meet immediate cash flow needs based on your unpaid invoices.